IEX •
Healthcare •
Biotechnology •
Quote as of 07/28/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization108.31 mln
Float40.07 mln
Earnings Date08/06/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.75
Likely reliable
Relative Strength
42
/ 100
Slightly lagging
Debt / Equity
0.09
Debt-free
ROE
-25.69
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Seer Inc. is a life sciences company based in Redwood City, California, that develops tools to help researchers study proteins at scale ? work that could ultimately lead to better health outcomes. Its main offering is the Proteograph Product Suite, a system combining specialized nanoparticles, lab instruments, and software to make large-scale protein analysis faster and more accessible to research labs. The company also provides complementary products for sample processing and data interpretation, and sells to universities, research institutions, and biotechnology and pharmaceutical companies across the US and several international markets. All products are intended for research purposes only and are not approved for clinical or diagnostic use.